Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Single and Multiple Doses of AL002 in Healthy Participants and in Participants with Mild to Moderate Alzheimer's Disease.
O'Brien, Terence
(Primary Chief Investigator (PCI))
Brodtmann, Amy
(Chief Investigator (CI))
Central Clinical School
Eastern Health Clinical School
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
30/05/19
→
31/12/19
View all
View less
Keywords
Neurological disorders
Alzheimer's disease
Clinical trial